SynCore Biotechnology Co., Ltd.(TW:4192)
NT$15.95-0.50 (-3.04%)
TW:4192
SynCore Biotechnology Co., Ltd. Revenue
NT$15.95
At close:-0.50 (-3.04%)
SynCore Biotechnology Co., Ltd. (4192) Revenue
SynCore Biotechnology Co., Ltd. Revenue
SynCore Biotechnology Co., Ltd. had a revenue of 6.28M in the quarter ending Jun 30, 2026, with 2.52%. This bring the company's revenue in the last twelve months to 26.24M, Decreased 5.54%. In the fiscal year ending Dec 31, 2025, SynCore Biotechnology Co., Ltd. had annual revenue of 27.04M with 15.88% growth.
- Revenue (ttm)
- 26.24M
- Revenue Growth
- -1.68%
- P/S Ratio
- 20.85
- Revenue/Employee
- TWD 676,075
- Employees
- 40
- Market Cap
- TWD 563.91M
Revenue Chart
SynCore Biotechnology Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.04M | 3.71M | 15.88% |
| Dec 31, 2024 | 23.34M | 3.14M | 15.55% |
| Mar 31, 2024 | 20.20M | 4.34M | 27.36% |
| Dec 31, 2022 | 15.86M | 8.92M | 128.52% |
| Dec 31, 2021 | 6.94M | -6.40M | -47.97% |
| Dec 31, 2020 | 13.34M | 369.00K | 2.85% |
| Dec 31, 2019 | 12.97M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.